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Abstract
A major goal in regenerative medicine is the predictable
manipulation of human embryonic stem cells (hESCs) to
defined cell fates that faithfully represent their somatic
counterparts. Directed differentiation of hESCs into neuronal
populations has galvanized much interest into their potential
application in modelling neurodegenerative disease.
However, neurodegenerative diseases are age-related, and
therefore establishing the maturational comparability of
hESC-derived neural derivatives is critical to generating
accurate in vitro model systems. We address this issue by
comparing genome-wide, exon-specific expression analyses
of pluripotent hESCs, multipotent neural precursor cells and
a terminally differentiated enriched neuronal population to
expression data from post-mortem foetal and adult human
brain samples. We show that hESC-derived neuronal
cultures (using a midbrain differentiation protocol as a
prototypic example of lineage restriction), while successful
in generating physiologically functional neurons, are closer
to foetal than adult human brain in terms of molecular
maturation. These findings suggest that developmental
stage has a more dominant influence on the cellular
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The ability to generate defined neuronal lineages from human
embryonic stem cells (hESCs) offers an unprecedented
opportunity to establish in vitro model systems of human
neurodegenerative diseases. Embryonic stem cells predict-
ably respond to developmental morphogenetic signals, thus
permitting the generation of specific neuronal types to enable
study of region-specific neurodegenerative conditions in vitro
(Lee et al. 2000; Kim et al. 2002; Wichterle et al. 2002;
Lang et al. 2004; Perrier et al. 2004; Schulz et al. 2004;
Bouhon et al. 2006). However, most neurodegenerative
diseases are age-dependent (Lees et al. 2009). Therefore, it
is important to determine to what extent hESC-derived
neurons, which represent a developmental model system,
resemble their adult counterparts not only morphologically
and physiologically but also in terms of gene expression.
Although neuronal cultures have been studied with regard
to specific genes such as MAPT (Iovino et al. 2010), to our
knowledge no attempt has been made to compare and map
hESC-derived neurons to region-specific comparators from
the foetal or adult brain in a genome-wide manner. In part
this is because of the relative scarcity of genome-wide data
from control post-mortem brain. Genome-wide gene expres-
sion analysis offers a powerful method to comprehensively
characterize temporally distinct stages of lineage restriction.
Recent advances in both microarray and RNA sequencing
technologies have allowed examination of splicing patterns
in parallel with overall expression levels and have yielded an
additional level of complexity to emerging studies (Yeo et al.
2007; Salomonis et al. 2010; Wu et al. 2010; Fathi et al.
2011). Using Affymetrix Exon arrays and next generation
RNA sequencing, alterations in expression levels and
splicing patterns during neuronal differentiation from hESCs
have been demonstrated (Yeo et al. 2007; Wu et al. 2010;
Fathi et al. 2011). However, this type of genome-wide
transcriptome analysis has not previously been used to
determine the maturational state of hESC-derived neuronal
cultures compared to foetal and adult human brain samples.
Generating electrophysiologically competent regionally de-
fined neurons from hESCs does not, in itself, provide
sufficient information regarding their maturational equiva-
lence to their adult somatic counterparts. However, compre-
hensive genome-wide approaches may permit further
meaningful analyses in this context. After all, it is now
recognized that 90 per cent of genes expressed in the human
brain are differentially regulated at the whole transcript or
exon level across brain regions and/or time, making it
possible to define regional and maturational cell states more
precisely (Kang et al. 2011).
Against this background, we used Affymetrix exon arrays
to investigate whole- genome gene expression and splicing to
study the genomic equivalence of hESC-derived neural
derivatives to foetal and adult human brain samples. Both
gene and exon-level expression data generated from these
arrays have been validated using TaqMan and Quantigene
assays by ourselves and others (Yeo et al. 2007; Johnson
et al. 2009; Kang et al. 2011; Trabzuni et al. 2011).
Expression profiles were analysed using a variety of
techniques including hierarchical clustering, principal com-
ponent analysis (PCA), Gene Ontology analysis and gene set
enrichment analysis (GSEA). By using a widely adopted
midbrain dopaminergic differentiation protocol as represen-
tative of a clinically relevant population, we were also able to
make inferences about how closely regionally defined (but
heterogeneous) hESC-derived neuronal populations resem-
bled their in vivo adult counterparts, given the growing use of
such culture systems to model neurodegenerative disease.
The major finding of our analysis was that hESC- derived
neurons more closely resemble foetal brain and further that
developmental stage is genomically a more significant
influence than regional identity. In addition, we demonstrate
that developmentally regulated splicing is a common finding
and that splicing indices may be a more accurate measure of
maturational state than gene level expression alone. These
findings have significant implications for studies aiming to
recapitulate an adult neurodegenerative disorder using human
pluripotent stem cells, and provide a robust platform for
studies aiming to uncover the molecular pathobiology of
ageing and neurodegeneration.
Materials and methods
Human embryonic stem cell (hESC) culture and neural induction
The hESC lines H9 (WiCell Research Institute (Madison, WI, USA)
and HuES9 (hES facility, Harvard University, Cambridge, MA,
USA) were propagated in chemically defined medium (CDM)
supplemented with FGF2, Activin (Harrington et al. 2006) and
insulin (all at a concentration of 10 ng/mL) as an adherent culture
system on a layer of mitotically inactivated mouse embryonic
fibroblasts as previously described (Joannides et al. 2007; Patani
et al. 2009). Human ESCs were enzymatically passaged in a 1 : 4 to
transcriptome than regional identity. In addition, we demon-
strate that developmentally regulated gene splicing is
common, and potentially a more sensitive measure of
maturational state than gene expression profiling alone. In
summary, this study highlights the value of genomic indices in
refining and validating optimal cell populations appropriate for
modelling ageing and neurodegeneration.
Keywords: dopaminergic neurons, hESC, human brain,
microarray, neurodegenerative disease, splicing.
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1 : 10 split ratio at the point of subconfluence. To generate neural
precursor cells, hESCs were enzymatically dissociated, mechani-
cally triturated then centrifuged before being washed in fresh
medium. Cell aggregates were next suspended in chemically defined
medium in 10-cm culture dishes on an orbital shaker. CDM
constituents are as follows: 50% IMDM (Gibco, Rockville, MD,
USA) plus 50% F12 plus Glutamax (Gibco), supplemented with
1.75 mM human recombinant insulin (Roche Molecular Biochem-
icals, Indianapolis, IN, USA), 0.38 mM transferrin (Roche),
450 lM of monothioglycerol (Sigma, St Louis, MO, USA),
10 lL/mL lipids (Sigma) and 5 mg/mL bovine serum albumin
fraction V (Sigma). Mitogen (FGF2 at 10 ng/mL) was introduced to
the cultures from day 8 for 8 days. At day 16, FGF2 was withdrawn
and FGF8 (200 ng/mL) and a sonic hedgehog agonist puromorph-
amine (Li et al. 2008) at a concentration of 1 lM were simulta-
neously administered for midbrain dopaminergic neuronal specifi-
cation. For terminal differentiation, midbrain precursors were plated
onto poly-D-lysine/laminin coated coverslips and cultured in
DMEM/2% B27/1%PSF, 10 ng/mL BDNF (R&D Systems) and
10 ng/mL GDNF (R & D Systems, Minneapolis, MN, USA) in the
absence of mitogens.
Reverse transcription-polymerase chain reaction (semi
quantitative)
Total RNA was extracted from dissociated and washed cells using
the RNeasy Mini Kit (Qiagen, Valencia, CA, USA) following the
manufacturer’s instructions. In the case of terminally differentiated
neuronal cultures, RNA extractions were performed at 59 days
in vitro. cDNA was synthesized from 2 lg of RNA using Moloney
murine leukaemia virus reverse transcriptase (Invitrogen, Carlsbad,
CA, USA) and oligo-dT primers. Polymerase chain reaction (PCR)
was carried out using Taq polymerase (Invitrogen). PCR products
were separated on a 2% agarose gel and visualized with SYBR-
Green (Invitrogen). Primer information is provided below:
PAX5 F: CCGAGCAGACCACAGAGTATTCA R: CAGTGAC
GGTCATAGGCAGTGG
ENGRAILED1 F: CTGGGTGTACTGCACACGTTAT R: TA
CTCGCTCTCGTCTTTGTCCT
ENGRAILED2 F: CCAGGTCTCGAAAACCAAAG R: CTAC
TCGCTGTCCGACTTGC
Immunocytochemistry
Cells plated down on poly-D-lysine/laminin coated glass coverslips
were fixed with 4% fresh paraformaldehyde for 20 min at 21C and
washed three times with PBS. Samples were next blocked for 1 h
with 0.3% Triton/PBS/5% goat serum and then incubated overnight
with primary antibody in 0.2% Triton/PBS/2% goat serum at 4C.
After three washes in PBS, secondary antibody (goat anti-mouse,
Alexa Fluor 488 or 555, 1 : 1000) in PBS/Hoechst (1 : 4000) was
next applied for 1 h. Primary antibodies included: NESTIN
(1 : 500; Chemicon, Temecula, CA, USA), b-III-TUBULIN
(1 : 500; Sigma-Aldrich), SYNAPSIN (1 : 500; Calbiochem, San
Diego, CA, USA), ENGRAILED1 (1 : 50; Developmental Studies
Hybridoma Bank, Iowa City, IA, USA), Musashi1 (1 : 500;
Chemicon).
Electrophysiological recordings
Whole-cell current-clamp and voltage-clamp recordings were made
from midbrain dopaminergic neurons at (21 ± 2C) using an
Axopatch-1C amplifier (Molecular Devices, Union City, CA,
USA) using methods as described previously (Baxter and Wyllie
2006; Soriano et al. 2008). Briefly, coverslips were transferred to a
recording chamber perfused with an external recording solution
composed of (in mM): 152 NaCl, 2.8 KCl, 10 HEPES, 2 CaCl2,
10 glucose pH 7.3 (320–330 mOsm). Patch pipettes were filled
with a K-gluconate-based internal solution containing (in mM):
155 K-gluconate, 2 MgCl2, 10 Na-HEPES, 10 Na-PiCreatine, 2
Mg2-ATP and 0.3 Na3-GTP, pH 7.3 (300 mOsm). For current-
clamp recordings, the external recording solution was supplemented
with antagonists of ionotropic glutamate, GABA and glycine
receptors (CNQX 5 lM; D-AP5, 50 lM, picrotoxin, 50 lM;
strychnine 20 lM). For the recording of whole-cell AMPA- and
NMDA-evoked currents and synaptically mediated glutamate receptor
responses, the external solution was supplemented with picrotoxin
(50 lM) and strychnine (20 lM). In all experiments where NMDA
receptor-mediated responses were studied, a saturating concentration
of the co-agonist, glycine (50 lM), was also added to the external
recording solution. Miniature excitatory post-synaptic currents
(mEPSCs) recorded in solutions supplemented with 300 nM
tetrodotoxin (TTX), picrotoxin (50 lM), strychnine (20 lM) and
MgCl2 (1 mM). Events were recorded for 5–10 min at a holding
potential of )70 mV.
Quantification and statistical analysis of cell cultures
A minimum of three biological repeats were utilized for all
experiments unless otherwise stated in the text. Cell counts were
performed across a minimum of five fields of view (approx. 90–350
cells per field) from a minimum of three biological experimental
repeats across two different hESC lines. A p value of < 0.05 was
considered statistically significant. Values are expressed as the mean
±SEM. The Mann-Whitney rank-sum test was used for non-
parametric analysis using Graph-Pad Prism 4 (Graph-Pad Software
Inc., San Diego, CA, USA).
Human foetal and adult brain and samples
Data for foetal brain gene expression originated from Johnson et al.,
Gene Expression Omnibus accession number GSE13344 (Johnson
et al. 2009). Post-mortem adult substantia nigra samples were
obtained from the MRC Sudden Death Brain and Tissue Bank at the
University of Edinburgh (www.edinburghbrainbanks.ed.ac.uk). A
detailed description of these tissue samples, isolation of mRNA,
quality control and validation can be found in Trabzuni et al.
(2011). A summary of all the samples used in this study is given in
Supporting Information Table S1.
RNA extraction and Exon Array processing
Total RNA was extracted from hESCs (n = 5), neural precursors
(n = 4) and terminally differentiated neurons (n = 3) using the
RNeasy kit (Qiagen, Crawley, UK) according to the manufacturer’s
instructions. In the case of post-mortem adult brain samples
(n = 57), total RNA was extracted using the miRNeasy kit (Qiagen)
according to the manufacturer’s instructions. Following the evalu-
ation of RNA quality using capillary electrophoresis (Agilent 2100
Bioanalyzer and RNA 6000 Nano Kit, Agilent Technologies,
Wokingham, UK), 200 ng of total RNA was used as starting
material for the cDNA preparation. All steps starting from the first
and second strand cDNA synthesis, the in vitro transcription
reaction to generate cRNA and the second round of cDNA synthesis
Journal of Neurochemistry  2012 International Society for Neurochemistry, J. Neurochem. (2012) 122, 738–751
 2012 The Authors
740 | R. Patani et al.
were performed using the Ambion WT Expression Kit (Ambion,
UK) according to the manufacturer’s instructions. Samples were
subsequently processed using the Affymetrix GeneChip Whole
Transcript Sense Target Labelling Assay and hybridized to the
Affymetrix Exon 1.0 ST Arrays following the recommended
Affymetrix protocols. Hybridized arrays were scanned on GeneChip
Scanner 3000 and visually inspected for hybridization artefacts.
Affymetrix EXPRESSION CONSOLE (EC) software version 1.1 was
used to evaluate the performance quality of the arrays including the
labelling, hybridization, scanning and background signals. Further
details regarding RNA isolation, processing and quality controls,
including validation of array-based estimates of gene expression are
reported in Trabzuni et al. (2011). Expression data on hESCs, neural
precursors, terminally differentiated neurons and post-mortem adult
brain samples have been submitted to Gene Expression Omnibus
(accession number GSE34865).
Analysis of exon array data
Exon Array data generated from hESCs (n = 5), neural precursors
(n = 4), terminally differentiated neurons (n = 3), post-mortem adult
brain samples originating from neuropathologically confirmed
controls (n = 57) and foetal brain tissue (n = 94) were pre-processed
using RMA quantile normalization with GC background correction
in Partek’s Genomics Suite v6.6 (Partek Incorporated, St. Louis,
MO, USA). Detection above background (DABG), p values of exon
probe sets were calculated using Affymetrix Power Tools v1.14.3
(APT, http://www.affymetrix.com/partners_programs/programs/
developer/tools/powertools.affx). Only probe sets with a median
DABG p value of < 0.001 for any single cell/tissue type, a
minimum of three probes within the set, unique hybridization and
designed against genes annotated within Entrez Gene (www.ncbi.
nlm.nih.gov/entrez/query.fcgi?db=gene) as documented in Netaffyx
annotation file (HuEx-1_0-st-v2 Probe set Annotations, CSV
Format, Release 31) were included in the analysis. Gene level
summary signals were generated by calculating the Winsorized
mean value (below 10% and above 90%) of all probe set signals
annotated to a single gene (transcript cluster). As most exons are
represented by only one probe set, we used the probe set signal
intensity as synonym of exon expression level, unless explicitly
mentioned. We defined an ‘expressed’ gene as any gene contain-
ing ‡ one exon with a median DABG p value < 0.001 in any given
sample set. State-specific expression and splicing was investigated
using Partek Genomic Suite’s mixed model ANOVA and alternative
splicing ANOVA (Partek Genomics Suite v6.6). To reduce the
likelihood of false positives, only probe sets that were called as
present in both cell/tissue types being compared were included
within the analysis. In all types of analysis, the date of array
hybridization was included as a co-factor to eliminate batch effects.
We used the FDR step-down method to correct p values for multiple
comparisons. Conservative statistical thresholds were used to
identify differentially expressed genes (FDR < 0.01 and minimum
fold difference > 1.7 between sample sets) and differentially spliced
genes (FDR < 1 · 10)5). Uncorrected p values are quoted within
the text. Unsupervized hierarchical clustering, PCA and Gene
Ontology analysis were performed using Partek Genomics Suite
v6.6 (Partek Incorporated). GSEA was performed using GSEA
v2.0.6 (Broad Institute, Cambridge, MA, USA) (Mootha et al. 2003;
Subramanian et al. 2005). Enrichment score p values were estimated
using an empirical phenotype-based permutation test procedure.
Results
Generation of hESC neural derivatives; NPCs and
physiologically functional regional neurons.
Using well established differentiation protocols, we neurally
converted OCT4 expressing pluripotent hESCS to first
musashi, nestin and PAX6 expressing NPCs; and then, by
application of FGF8 and a sonic hedgehog agonist (pur-
omorphamine), to PAX5, EN1 (Engrailed 1) and EN2
expressing precursors (Fig. 1d and e). Importantly, these
midbrain precursors plated at day 24 for a further 35 days
(total days in vitro 59) generated highly enriched neurons
that expressed ß-III-tubulin (84.1 ± 1.6%; Supporting Infor-
mation Figure S1A), synapsin (89.4 ± 1.3%; Supporting
Information Figure S1B) with evidence of a midbrain
dopaminergic neuronal identity as demonstrated by EN1
expression (31.8.0 ± 2.0%; Fig. 1e and Supporting Informa-
tion Figure S1C) and b-III-tubulin/Tyrosine hydroxylase
(TH) co-immunolabelling (41.7.0 ± 3.1%; Fig. 1f and Sup-
porting Information Figure S1D). Electrophysiological
assessment of TH expressing neurons demonstrated firing
of action potentials when injected with depolarizing currents
(Fig. 1g). In addition, they possessed receptors for ionotropic
glutamate receptors, as evidenced by whole-cell current
recordings in response to the application of a-amino-3-
hydroxyl-5-methyl-4-isoxazole-propionate (AMPA; Fig. 1h).
Receptors for the inhibitory neurotransmitter, c-aminobutyric
acid (GABA), were also present in these cells (Fig. 1i).
Finally, synaptic connectivity was evident by the presence of
miniature excitatory synaptic post-synaptic currents. To-
gether, these data are consistent with the generation of a
subpopulation (approximately 30%) of functional human
midbrain dopaminergic neurons from hESCs within a
population of highly enriched neuronal cultures ( > 80%).
Genome-wide gene expression analyses at developmentally
distinct phases of lineage restriction
To examine the relationship between hESCs, NPCs and
terminally differentiated physiologically active neurons,
whole-genome gene expression and mRNA splicing analysis
using Affymetrix Exon arrays was undertaken. Unsupervized
hierarchical clustering analysis and PCA revealed expected
segregation of replicates with hESCs, NPCs and differenti-
ated neurons forming distinct groups, with the hESC and
NPC populations more closely related than differentiated
neurons (Fig. 2a and b). To further characterize gene
expression differences, the expression profiles (i) hESCs
and NPCs and (ii) NPCs and differentiated neurons were next
compared. This method detected genes expressed only in a
single culture type, genes differentially expressed between
cultures (as defined as a fold change of ± 1.7 and passing an
FDR of 0.01) and genes, which were differentially spliced
between cultures (passing an FDR of 1 · 10)5). This
analysis confirmed the findings of hierarchical clustering by
 2012 The Authors
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demonstrating that there were fewer gene expression differ-
ences between hESCs and NPCs, than between NPCs and
differentiated neurons and also revealed that the majority of
gene expression differences between NPCs and differentiated
neurons were as a result of differential gene expression rather
than expression of unique genes (Fig. 2c and d). Further-
more, this analysis demonstrated that differential splicing is
common during neural differentiation and is likely to be no
less important than–the more often studied–differential gene
expression, particularly when comparing NPCs to differen-
tiated neurons.
Using Gene Ontology analysis, we next focused on genes
that passed an FDR of 0.01 and had at least 1.7-fold higher
expression in (i) NPCs compared with hESCs, and (ii)
terminally differentiated neurons as compared with NPCs.
Consistent with previous reports, we found that genes
involved in nervous system development (enrichment
p value = 9.28 · 10)10) and synapse assembly (enrichment
p value = 2.20 · 10)9) were significantly over-represented
in NPCs compared to hESCs (Wu et al. 2010). Further
enrichment of nervous system related genes was also
apparent in terminally differentiated neurons compared to
NPCs. Not only were genes involved in nervous system
development (enrichment p value = 1.13 · 10)12) and syn-
apse assembly (enrichment p value = 2.96 · 10)9) signifi-
cantly over-represented in terminally differentiated neurons
as compared to neural precursors, but so were genes involved
more specifically in central nervous system development
(enrichment p value = 3.80 · 10)9) and axon guidance
(enrichment p value = 2.64 · 10)10). However, the most
significant finding was the significant over-representation of
genes related to cell adhesion (enrichment p value =
3.59 · 10)25).
Given data from previous studies demonstrating dynamic
expression of PAX6, DCX, MAP2 and HES1 during neural
differentiation, we investigated the expression of these genes
in our own data set (Wu et al. 2010). Consistent with earlier
reports, we found that expression of PAX6, DCX and MAP2
increased significantly during neural differentiation (PAX6
p value = 7.83 · 10)5, DCX p value = 9.87 · 10)5, MAP2
p value = 2.86 · 10)4). HES1 expression appeared to be
maximal in NPCs (Fig. 3a).
(a)
(f) (g) (j)
(h)
(i)
(b)
(c)
(d) (e)
Fig. 1 Specification of functional midbrain dopaminergic neurons from
human embryonic stem cells (hESCs). (a–c) Neural induction from
hESCs in chemically defined medium using a suspension culture
system leads to progressive loss of pluripotency marker OCT4 and
concomitant acquisition of neuroectodermal markers PAX6, MUSASHI
and NESTIN by day 16. (d) The application of FGF8 and a sonic
hedgehog agonist (puromorphamine) from day 16 to 24 increases the
expression of PAX5, EN1 (Engrailed 1) and EN2, markers associated
with midbrain dopaminergic neurons. (e–f) Terminal differentiation to a
midbrain dopaminergic neuronal identity was demonstrated by EN1
expression and b-III-tubulin/Tyrosine hydroxylase (TH) co-immunola-
belling. (g) Electrophysiological assessment of TH expressing neurons
showed them to fire action potentials when injected with depolarizing
currents. (h) In addition, they possessed receptors for ionotropic glu-
tamate receptors, as evidenced by whole-cell current recordings in
response to the application of a-amino-3-hydroxyl-5-methyl-4-isoxaz-
ole-propionate (AMPA). (i) Receptors for the inhibitory neurotrans-
mitter, c-aminobutyric acid (GABA) were also present in these cells. (j)
Finally, synaptic connectivity was evident by the presence of miniature
excitatory synaptic post-synaptic currents indicated by ‘*’. Scale bars:
B&C 100 lm, E 250 lm, F 50 lm and G 10 lm.
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Finally, we investigated alternative splicing during neuro-
nal differentiation. Of the 13 625 multi-exon genes detected
in both hESCs and neural precursors, 13.8% (1882) were
identified as being alternatively spliced by cell type using a
conservative FDR of 1 · 10)5. A similar analysis comparing
NPCs and terminally differentiated neurons demonstrated
that 29.9% (4324 of 14 440) of multi-exon genes detected in
both samples had evidence of alternative splicing. An
illustrative example is SLK where hESCs expressed the
full-length isoform of SLK containing all exons, consistent
with other studies (Yeo et al. 2007; Wu et al. 2010), and
during the process of neural differentiation, the shorter
isoform–lacking exon 13 – became dominant (Fig. 3b)
(alternative splicing p value = 1.51 · 10)22, Supporting
Information Figure S2). This appeared to be a gradual
process such that NPCs expressed a mixture of both
isoforms, whereas differentiated neurons expressed the short
isoform of SLK. Thus, splicing is an important source of
transcriptomic variation during the process of neural differ-
entiation, no less important than the more frequently
measured changes in gene expression levels.
Comparison of hESC-derived neuronal cultures to
human foetal and adult brain expression profiles
To relate the gene expression phenotype in hESC-derived
neurons to the in vivo situation, we compared these data to
archival data generated on the same platform from human
foetal brain tissue (Johnson et al. 2009) and an additional
(a)
(b) (c)
(d)
Fig. 2 Gene expression profiling during
neural differentiation in culture. (a) Unsu-
pervized hierarchical clustering of hESC,
NPCs and differentiated neuron exon-le-
vel expression profiles demonstrates
separation of each cell type with human
embryonic stem cells (hESCs) and NPCs
profiles being most closely related. (b)
Principal component analysis (PCA) con-
firms the separation of each cell type,
hESC, NPCs and differentiated neurons.
(c) Bar chart to show the % of all genes
detected in two sequential stages of
neural differentiation, either hESC and
NPCs (hESC v NP) or NPCs and differ-
entiated neurons (NP v TD), that are (i)
only called present in one cell type, (ii)
differentially expressed between cell
types and (iii) differentially spliced be-
tween cell types. (d) Gene expression
scatter plots comparing the hESC and
NPC expression profiles, and the NPC
and differentiated neuron expression
profiles demonstrate that global gene
expression in hESCs and NPC is more
similar than NPCs and differentiated
neurons.
 2012 The Authors
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data set generated within our laboratory from human adult
substantia nigra (Trabzuni et al. 2011). The former data set
consisted of samples originating from foetal cerebellum
(n = 5), thalamus (n = 7), hippocampus (n = 8), striatum
(n = 8) and neocortex (n = 66). Unsupervized hierarchical
clustering and PCA revealed that the different populations
segregated into the three ‘developmental’ groups, namely
adult brain tissue, foetal brain tissue and hESC-derived
neurons (Fig. 4a and b). Interestingly, when compared to
both foetal brain samples (all regions) and adult brain, the
differentiated neuronal (hESC-derived) cells appeared to be
most closely related to foetal tissue samples, whatever their
regional identity. As this would suggest that maturational
state as opposed to regional identity was most significant,
from this point on we refer to all foetal brain samples
collectively as ‘foetal brain tissue’.
Closer inspection of the results would suggest that this
finding was driven primarily by the greater overlap in
expression of genes called as expressed between differenti-
ated neuronal cultures and foetal brain tissue, as compared to
neuronal cultures and adult brain (Fig. 4c and d). In both
types of analysis, the majority of genes detected in a single
state were expressed in differentiated neurons. Focusing on
the gene sets uniquely expressed in differentiated neurons
and using Gene Ontology analysis, we found an enrich-
ment of genes involved in response to stimulus (enrichment
p value = 2.39 · 10)7) and growth (enrichment p
value = 0.013) in differentiated neurons versus foetal brain
tissue, and in cell growth (enrichment p value = 1.23 x 105),
cell proliferation (enrichment p value = 0.003) and response
to stimulus (enrichment p value = 0.043) in the differentiated
neurons versus adult substantia nigra. Conversely, using
Gene Ontology analysis to investigate genes not detected in
neuronal cultures, but present in foetal and adult brain tissue,
we found an enrichment of genes involved in cell–cell
signalling (enrichment p value = 2.66 · 10)9), immune
response (enrichment p value = 3.37 · 10)9 and multicellu-
lar organismal development (enrichment p va-
lue = 4.30 · 10)9). Further insights were obtained by
looking specifically at genes associated with myelination
(MBP), oligodendrocytes (OLIG1), astrocytes (GFAP) and
microglia (FCER1G) (for the full list of genes tested see
Supporting Information Table S2) (17). All four genes were
expressed at significantly higher levels in adult substantia
nigra (MBP, p value = 4.86 · 10)14, fold change = 12.08;
OLIGO1, p value = 1.82 · 10)23, fold change = 18.58;
GFAP, p value = 2.93 · 10)21, fold change = 100.34;
FCER1G, p value = 4.50 · 10)9, fold change = 6.51) with
very similar levels of expression in neuronal cultures and
foetal brain tissue (Fig. 4e).
(a)
(b)
Fig. 3 Dynamic gene expression and
splicing during neural differentiation. (a)
Bar chart showing DCX, PAX6, HES1 and
MAP2 expression ± SEM in human
embryonic stem cells (hESCs), NPCs and
differentiated neurons. (b) Gene level and
exon-specific expression data for SLK in
hESCs, NPC cells and differentiated
neurons demonstrates that while there is
no significant difference in SLK gene level
expression in hESCs, NPC cells and dif-
ferentiated neurons, expression of exon
13 becomes significantly lower during
neural differentiation (alternative splicing
p value = 1.51 · 10)22).
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We also identified genes that were (i) differentially
expressed between conditions, as defined as a fold change
of ± 1.7 between states and passing an FDR of 0.01, and
(ii) genes which while they might have been expressed at
similar levels between states were differentially spliced as
defined as passing an FDR of 1 · 10)5 using the
alternative splicing ANOVA. Together these findings show
that differential splicing is an important source of variation
between hESC-derived neuronal cultures and in vivo
tissues both foetal and adult. Indeed, the finding that
differential splicing was the most frequent observation
between hESC-derived neurons and adult tissue empha-
sizes the significance of maturation-dependent differential
splicing (Fig. 4c). Illustrative analysis of NCAM1 and
MAPT, two well-studied genes that are known to be
spliced in a developmentally regulated manner, differential
splicing (as opposed to differential gene expression) made
it possible to distinguish between adult, as compared to
foetal or hESC-derived cell samples (Fig. 5a and b). For
example, NCAM1 is spliced to generate three main
isoforms, the protein products of which are commonly
known as NCAM-180, NCAM-140 and NCAM-120.
Whereas NCAM-180 and NCAM-140 have the highest
expression during foetal and early post-natal development,
NCAM 120 is found at low levels in foetal brain, but
increases in expression and is expressed at stable levels in
(a)
(b)
(d)
(e)
(c)
Fig. 4 Gene expression profiling in dif-
ferentiated neurons, foetal brain tissue
and adult human substantia nigra. (a)
Unsupervized hierarchical clustering of
expression profiles from differentiated
neurons, foetal brain tissue and adult
substantia nigra demonstrates that while
each cell/tissue type clusters separately,
terminally differentiated neurons and foe-
tal brain tissue expression profiles are
most closely related. (b) Principal com-
ponent analysis (PCA) confirms the sep-
aration of each cell/tissue type,
differentiated neurons, foetal brain tissue
and adult substantia nigra. (c) Bar chart to
show the % of all genes detected in two
sequential stages of neural differentiation,
either differentiated neurons and foetal
brain tissue (DN vs. Foetal) or differenti-
ated neurons and adult substantia nigra
(DN vs. SNIG), that are (i) only called
present in one cell type, (ii) differentially
expressed between cell types and (iii)
differentially spliced between cell types.
(d) Venn diagrams showing the overlap in
genes called as expressed within differ-
entiated neurons and foetal brain tissue
(Foetal vs. DN), as compared with differ-
entiated neurons and adult substantia ni-
gra (Adult SNIG vs. DN). (e) Bar chart
showing MBP, OLIGO1, GFAP and
FCER1G expression ± SEM in differenti-
ated neurons, foetal brain tissue and adult
substantia nigra.
 2012 The Authors
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adult (Cox et al. 2009). In keeping with these findings, we
found that expression of the 3¢UTR (as measured by
three probe sets on the Affymetrix Exon Array) unique to
NCAM-120 were expressed at similar levels in differen-
tiated neurons and foetal brain tissue, but had higher
expression in adult brain (alternative splicing p va-
lue < 1.0 · 10)45) (Fig. 5a, Supporting Information Fig-
ure S3). Similarly, MAPT is alternatively spliced at exons
3 and 10, and analysis of the differentiated neuronal cells
and foetal tissue show that both of these exons are
expressed at significantly lower levels compared to the
adult brain (alternative splicing p value < 1.0 · 10)45)
(Fig. 5b, Supporting Information Figure S4). This is in
accordance with previous developmental data and data
from a previously published study from us (Andreadis
2005; Iovino et al. 2010).
Gene set enrichment analysis to specifically investigate
synapse formation
Investigating the differential expression of single genes will
underestimate differences in the expression of entire gene
networks that are subtle at the level of any single gene, but
are nonetheless significant when all the genes in the pathway
are considered. To address this issue, we used the Broad
Institute’s Molecular Signatures Database and GSEA
software (v2.0.6) to identify gene sets related to pre- and
post-synaptic signalling, namely the Reactome ‘neurotrans-
mitter release cycle’ and ‘neurotransmitter receptor binding
and downstream transmission in the post-synaptic cell’
(Fig. 6). GSEA revealed that both pathways are up-regulated
in differentiated hESC-derived neurons as compared to NPCs
(Reactome ‘neurotransmitter release cycle’, nominal
p value = 0.012, FDR q value = 0.007; Reactome ‘neuro-
transmitter receptor binding and downstream transmission in
the post-synaptic cell’, nominal p value < 1.0 · 10)3, FDR
q value = 1.0 · 10)3). However, investigating the expres-
sion of these pathways in foetal brain tissue (Reactome
‘neurotransmitter release cycle’, nominal p value = 0.003,
FDR q value = 0.005; Reactome ‘neurotransmitter receptor
binding and downstream transmission in the post-synaptic
cell’, nominal p value = 1.0 · 10)3, FDR q value = 0.009)
and adult substantia nigra (Reactome ‘neurotransmitter
release cycle’, nominal p value = 0.005, FDR q va-
lue = 0.003; Reactome ‘neurotransmitter receptor binding
and downstream transmission in the post-synaptic cell’,
nominal p value = 0. 0.029, FDR q value = 0.059) demon-
strated that both pathways are more highly expressed in these
tissue types than neuronal cultures. This would suggest that
while hESC-derived neurons are capable of releasing and
responding to neurotransmitters, neither the pre-synaptic nor
post-synaptic machinery is expressed at foetal or adult levels.
Conversely, a similar analysis investigating the KEGG
(a)
(b)
Fig. 5 Differential splicing of NCAM1 and
MAPT in differentiated neurons, foetal
brain tissue and adult substantia nigra. (a)
Gene level and exon-specific expression
data for NCAM1 demonstrate that while
there is no significant difference in
NCAM1 gene level expression in differ-
entiated neurons, foetal brain tissue or
adult substantia nigra, expression of the
3¢ UTR specific to NCAM-120 has a sig-
nificantly higher expression in adult sub-
stantia nigra as compared to foetal brain
tissue or differentiated neurons (alterna-
tive splicing p value < 1.0 · 10)45). (b)
Gene level and exon-specific expression
data for MAPT demonstrate that while
MAPT at the gene level is expressed at
high levels in differentiated neurons, foe-
tal brain tissue and adult substantia nigra,
expression of exons 2 and 10 is signifi-
cantly higher expression in adult sub-
stantia nigra as compared to foetal brain
tissue or differentiated neurons (alterna-
tive splicing p value < 1.0 · 10)45).
Journal of Neurochemistry  2012 International Society for Neurochemistry, J. Neurochem. (2012) 122, 738–751
 2012 The Authors
746 | R. Patani et al.
mTOR signalling pathway demonstrated no enrichment of
this pathway between hESC-derived differentiated neurons
and NPCs (nominal p value = 0.367, FDR q value = 0.381),
differentiated neurons and foetal brain tissue (nominal
p value = 0.316, FDR q value = 0.334), and finally differ-
entiated neurons and adult brain tissue (nominal p
value = 0.703, FDR q value = 0.718) (Fig. 6). This would
suggest that this pathway matures early and is expressed at
similar levels in all three maturational states.
Discussion
Human pluripotent cells represent a potentially limitless
source of neurons for further study, both as an experimental
resource and potentially as a cell-based repair strategy in
neurodegenerative disease. A major limitation to using
human stem cell derivatives as either a therapeutic treatment
or as model systems for examining neurodegenerative
diseases is the relative lack of information regarding the
(a)
(b)
(c)
Fig. 6 Gene set enrichment analysis (GSEA) for three pathways rel-
evant to neural differentiation. (a) GSEA for the Reactome neuro-
transmitter release cycle demonstrates significant enrichment of this
pathway in differentiated neurons as compared to NPC cells (DN vs.
NP), in addition to enrichment of this pathway in foetal brain tissue and
adult substantia nigra relative to differentiated neurons (DN vs. Foetal,
DN vs. SNIG). (b) GSEA for the Reactome neurotransmitter receptor
binding and downstream transmission pathway demonstrates
significant enrichment of this pathway in differentiated neurons as
compared to NPC cells (DN vs. NP), in addition to enrichment of this
pathway in foetal brain tissue and adult substantia nigra relative to
differentiated neurons (DN vs. Foetal, DN vs. SNIG). (c) GSEA for the
KEGG mTOR signalling pathway provides no evidence for significant
enrichment of this pathway in neural precursors, foetal brain tissue or
adult substantia nigra on comparison with differentiated neurons (DN
vs. NP, DN vs. Foetal, DN vs. SNIG).
 2012 The Authors
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functional and molecular maturational state of differentiated
neuronal populations in relation to the ageing human brain
(Lees et al. 2009). One way of approaching this is to
examine alterations in expression of genes over the course of
the differentiation process and in reference to human foetal
and adult brain tissue. Advances in genome-wide array
technology allow an unbiased analysis of the entire genome,
with both gene and exon-specific expression quantified. In
this study, we have analysed whole-genome gene expression
using an exon array platform, yielding a detailed map of gene
expression and splicing in three temporally distinct cellular
stages in the process of neural conversion from pluripotent
stem cells. This allowed us to compare these gene expression
phenotypes to those observed in the human foetal and adult
brain and thus characterize their utility in modelling neuro-
degenerative disease in vitro.
The analysis presented in this article represents the first
report of genome-wide mRNA expression and splicing
during the process of directed differentiation from hESCs
to a terminally differentiated neuronal population. It provides
a platform for the analysis of targeted differentiation of
pluripotent human cells into defined neuronal populations,
related to their in vivo counterparts. Analysis of our mRNA
expression data from the hESC, NPC and differentiated
neuronal populations confirms that the phenotypic changes in
the properties and function of cell populations cultured
ex vivo can be followed via the medium of gene expression, a
finding that is consisistent with previous genome-wide
expression studies of this nature (Yeo et al. 2007; Wu et al.
2010; Fathi et al. 2011). As the differentiation process is
followed, there is increasing disparity between the expression
profiles of these cells, with greater difference observed
between NPCs and differentiated neuronal cells than between
hESCs and NPCs – demonstrating an overlap within
precursor or cycling cell populations and increased special-
ization upon lineage restriction. This is confirmed by
unsupervized hierarchical clustering and PCA; the three cell
populations can be clearly separated, with each set displaying
close grouping suggesting that the differentiation process
results in reproducible populations.
These data highlight the utility of genome-wide expression
analysis as a quality control measure for following differen-
tiation and assessing the robustness of a differentiation
protocol. A detailed analysis of the type of expression
differences between the cell cultures revealed that although
expression of unique genes and differential gene expression
is important, differential splicing is also a major cause of
transcriptomic variation particularly when comparing NPCs
to neuronal cultures. In the case of both differential gene
expression and splicing, we were able to replicate and
expand on a previous study using RNA sequencing of hESCs
(Wu et al. 2010). Similarly, we showed that hESCs express
the full-length isoform of SLK and that during the process of
neural differentiation, the shorter isoform lacking a single
exon becomes dominant. As SLK splicing has been previ-
ously demonstrated using both RNA sequencing (Wu et al.
2010) and qPCR (Yeo et al. 2007), this example also
provides strong validation for the splicing changes predicted
using the Affymetrix Exon array.
An insight into the nature of increasing complexity in
neural tissue as it develops is yielded by our analysis of the
differential expression and splicing of genes between sample
sets. A key finding of this study is that, in addition to
differential gene expression, differential splicing is a com-
mon finding. This highlights the importance of altered
splicing in establishing the complexity and diversity of a
fully formed neuronal system, as well as the importance of
assessing splicing as a measure of expression phenotype in
hESC-derived neuronal populations used as model systems.
Although it might be argued that differential splicing
between neuronal cultures and in vivo samples is being
overestimated possibly because of the higher cellular diver-
sity within foetal brain tissue and adult brain, it should be
noted that only exons called as present within all sample
types were analysed for evidence of alternative splicing; thus
reinforcing the validity of our findings.
Focusing on the terminally differentiated hESC-derived
neurons, foetal and adult brain data sets, the groups of genes
that are uniquely expressed by the hESC-derived neuronal
cultures are informative as to the nature of the differences
between these samples. The clearest difference between the
hESC-derived neurons and the foetal brain samples is in
genes linked to response to stimulus and growth, suggesting
that growth-related signalling is still highly active within the
cultures. Between the hESC-derived neurons and adult brain
data set, growth and cell proliferation standout as major gene
groups that are differentially expressed between the two
sample sets. However, it is also clear that at least some of the
differences between neuronal cultures and adult brain (in
particular) arise from the expression of cellular systems and
types that are not present in culture systems. Among the
genes not expressed in cultures, but called present in vivo,
there was a clear enrichment of genes associated with cell–
cell signalling, immune response and multicellular organis-
mal development.
Similarly, focusing on the expression of genes specifically
associated with myelination, oligodendrocytes, astrocytes
and microglia demonstrated the higher expression of these
cell types in adult brain as compared with both foetal tissue
and neuronal cultures. The expression data presented in this
article comes from mixed cell populations, both with regard
to the differentiated cellular samples and the post- mortem
samples. In particular, and as demonstrated in previous
similar studies (Li et al. 2005; Joannides et al. 2007; Patani
et al. 2011), the hESC-derived neuronal population is likely
to contain a higher neuron ( ‡ 85%) to glia ( £ 5–10%) ratio
when compared with the post-mortem samples (where glia
are likely to outnumber neurons). Some of the genome-wide
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gene expression differences identified between hESC-derived
neurons and their foetal and adult counterparts may well
reflect their different lifespan and developmental environ-
ment/signalling milieu. It may indeed be of interest in future
studies to employ ex vivo cultured adult neuronal primary
cells (e.g. from brain biopsy material) to compare expression
profile differences with their in vitro hESC-derived counter-
parts. A direct comparison between primary neuronal
populations and ESC derived neuronal cells could also be
achieved under more controlled conditions using murine
derived cells. In terms of more closely modelling the in vivo
situation, establishing carefully controlled hESC-derived co-
cultures (neurons and glia) may enable more representative
comparisons to be made to the post-mortem adult brain on a
cell population level. This will be of particular importance
with regard to studying the non-cell autonomous aspects of
neuronal degeneration, as evidenced by experimental data
from familial forms of amyotrophic lateral sclerosis (Ilieva
et al. 2009).
When expression data from hESC-derived neuronal
cultures (containing approximately 30% midbrain dopami-
nergic neurons) is compared with profiles from human foetal
brain tissue and adult brain (substantia nigra), there is clear
clustering of the expression data set from these samples with
foetal brain tissue, highlighting the expression phenotype
similarities between these data sets. The finding of compar-
ative maturational equivalence between hESC-derived neu-
ronal populations and foetal (not adult) brain tissue has
important implications for stem cell-based approaches to
modelling neurological disease. Notwithstanding that recent
human iPSC studies have reported phenotypes for both
inherited and sporadic adult brain disorders, our findings
raise important questions and offer insights around how
adult-onset neurogenetic diseases can be optimally modelled
in vitro using patient-derived, disease-specific induced
pluripotent stem cells (iPSCs) (Wichterle and Przedborski
2010; Brennand et al. 2011; Nguyen et al. 2011; Bilican
et al. 2012). In contrast to neuro-developmental disorders
such as spinal muscular atrophy (Ebert et al. 2009), familial
dysautonomia (Lee et al. 2009) and Rett’s syndrome
(Marchetto et al. 2010), our study suggests strongly that
modelling the adult context of disease requires a more
complex culture model that seeks to reflect both glial
enrichment and simulation of age-related pathological
changes.
The purpose of our study was to identify differences in
gene expression between currently used human pluripotent
stem cell-based differentiation protocols and their somatic
counterparts at later developmental stages to provide insight
into the validity of current stem cell-based approaches to
model neurological disease. This study highlights important
differences between current in vitro strategies attempting to
model neurodegeneration and the in vivo adult context. Our
findings provide a platform for future strategies aiming to
resolve the molecular pathogenesis of ageing and neurode-
generation, for example in conditions such as Parkinson’s
and Alzheimer’s diseases.
In conclusion, our analyses suggest a potential hierarchi-
cal paradigm where developmental stage plays a greater role
in regulating gene expression than regional identity of
neuronal populations. The finding that the maturational state
of hESC-derived terminally differentiated neurons is closer
to that of foetal (not adult) neurons highlights the current
limitations of in vitro modelling of adult neurodegenerative
disease. In turn, this raises various experimental opportuni-
ties around ‘accelerating’ the developmental stage of
neuronal cultures to more closely resemble their adult
counterparts, and thus serve as more representative in vitro
model systems to study human age-related neurological
disease.
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Figure S1. Quantitative immunocytochemistry for midbrain
dopaminergic neuron specification from hESCs.
Figure S2. Plotted are expression levels (y-axis) for each probe
set (x-axis) for SLK, which shows a statistically significant
interaction between probe set expression (‘exon usage’) and cell
type.
Figure S3. Plotted are expression levels (y-axis) for each probe
set (x-axis) for NCAM1, which shows a statistically significant
interaction between probe set expression (‘exon usage’) and cell/
tissue type.
Figure S4. Plotted are expression levels (y-axis) for each probe
set (x-axis) for MAPT, which shows a statistically significant
interaction between probe set expression (‘exon usage’) and cell/
tissue type.
Table S1. Sample details.
Table S2. Table to show the genes and their associated cell types
and processes that have been tested for significant changes in
expression between neuronal cultures and foetal brain tissue or adult
substantia nigra.
As a service to our authors and readers, this journal provides
supporting information supplied by the authors. Such materials
are peer-reviewed and may be re-organized for online delivery,
but are not copy-edited or typeset. Technical support issues
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